Conclusions
High-quality evidence exist for the effect of ACEIs/ARBs on some
COVID-19 clinical outcomes. For the first time, we provided evidence,
albeit of low quality, on inter-class differences between ACEIs and ARBs
for some of the reported clinical outcome.